drugset / Trial / NCT02720783

Tolerability and Pharmacokinetic Study of Econazole Nitrate Plus Benzydamine HCl Vaginal Pessary

NCT02720783

Phase 1 Completed 49 enrolled Angelini Pharma Cross Research S.A. · collab
RandomizedParallel-groupTriple-blindOther

Summary

The primary objective of the study is to evaluate the local tolerability of the new Econazole/Benzydamine pessary, in comparison with Econazole and Benzydamine stand-alone products and placebo. Pharmacokinetics of the study products after single and multiple applications o.d. for 3 days, overall local and general tolerability, safety and comfort of use will also be evaluated.

Timeline

Start
2016-03-04
Primary completion
2016-10-12
Completion
2016-10-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzydamine Unknown 6 mg Other
Subject Econazole Unknown 150 mg Other

Indications

No indication recorded.